BK virus, first isolated in 1971, is a significant risk factor for renal transplant dysfunction and
allograft loss. Unfortunately, treatment options for BK virus infection are limited, and there is …

Percutaneous needle core biopsy is the definitive procedure by which essential diagnostic
and prognostic information on acute and chronic renal allograft dysfunction is obtained. The …

The present AST‐IDCOP guidelines update information on BK polyomavirus (BKP yV)
infection, replication, and disease, which impact kidney transplantation (KT), but rarely non …

The human BK polyomavirus (BKV) is the major cause of polyomavirus-associated
nephropathy (PyVAN) putting 1–15% of kidney transplant patients at risk of premature …

Polyomavirus nephropathy (PVN) is a common viral infection of renal allografts, with biopsy-
proven incidence of approximately 5%. A generally accepted morphologic classification of …

Human polyomaviruses (HP yVs) are a growing challenge in immunocompromised patients
in view of the increasing number of now 12 HP yV species and their diverse disease …

Reactivation of BK virus in renal allografts causes a destructive chronic infection. This single-
center retrospective cohort study describes the evolution of BK virus allograft nephropathy …

Polyomavirus BK (BKPyV) infects most people subclinically during childhood and
establishes a lifelong infection in the renourinary tract. In most immunocompetent …

The classical lytic infection theory along with large T antigen-mediated oncogenesis cannot
explain the BK polyomavirus (BKPyV)-associated tumor secondary to BKPyV-associated …

Results Risk for BKVAN was greater among ABO-incompatible than HLA-incompatible
patients (17.7% versus 5.9%; P= 0.008). Of BKVAN cases, 42% were subclinical, diagnosed …